Reasons for Treatment (Tx) Discontinuation Among Hepatitis C (HCV) Patients Treated in Clinical Practice

被引：0
作者：
Yood, Marianne Ulcickas [1 ]
Sapra, Sandhya [2 ]
Oliveria, Susan A. [1 ]
Casso, Deborah [1 ]
Fu, An-Chen [3 ]
L'Italien, Gilbert [2 ]
机构：
[1] EpiSource, Newton, MA USA
[2] Bristol Myers Squibb Co, Plainsboro, NJ USA
[3] HealthCore, Wilmington, DE USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1746
引用
收藏
页码：1005A / 1005A
页数：1
相关论文
共 50 条
  • [21] Impact of Age on Safety and Treatment Response in Patients with Hepatitis C (HCV) Treated With Boceprevir or Telaprevir
    Aronsohn, Andrew
    Stainbrook, Tuesdae
    Mohanty, Smruti
    Mubarak, Abdullah
    Spivey, James
    Pandya, Prashant K.
    Stewart, Thomas
    Fried, Michael W.
    Jacobson, Ira M.
    HEPATOLOGY, 2013, 58 : 218A - 218A
  • [22] The impact of antiretroviral treatment on the clinical course of hepatitis C in patients coinfected with HIV and HCV
    Bakowska, E
    Gizinska, J
    Podlasin, R
    Jagodzinska-Hamann, L
    Horban, A
    AIDS, 1998, 12 : S88 - S88
  • [23] Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice
    Marniquet, M. -E.
    Seneschal, J.
    Darrigade, A. -S.
    Staumont-Salle, D.
    Jachiet, M.
    Nosbaum, A.
    Tauber, M.
    Abasq, C.
    Ferrier Le Bouedec, M. -C.
    Droitcourt, C.
    Aubert, H.
    Bernier, C.
    Soria, A.
    Raison-Peyron, N.
    Tetart, F.
    Aubin, F.
    Viguier, M.
    Valois, A.
    Kupfer-Bessaguet, I.
    Goronflot, T.
    Barbarot, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 733 - 735
  • [24] Medical reasons for dose adjustment and/or discontinuation of mitoxantrone in clinical practice
    Annette, Wundes
    Kraft, George
    Bowen, James
    Gooley, Ted
    Nash, Richard
    NEUROLOGY, 2008, 70 (11) : A94 - A94
  • [25] Molecular Evolution of Hepatitis C Virus (HCV) and Clinical Outcome in Patients with Hepatitis C
    Farci, Patrizia
    Wollenberg, Kurt
    Alter, Harvey J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 : 68 - 68
  • [26] Hepatitis C (HCV) Treatment Progress and SVR of Combination Therapy in Practice
    El-Hamdi, Nadia
    Chen, Frankie
    Cloyd, Aya
    Alam, Imtiaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S673 - S673
  • [27] Effectiveness of antiviral therapy in patients with chronic hepatitis C treated in daily clinical practice
    Goulis, John
    Manolakopoulos, Spilios
    Savvidou, Savvoula
    Tsekoura, Panagiota
    Papatheodoridis, George V.
    Triantos, Christos
    Anagnostou, Olga
    Chrysanthos, Nikolaos
    Thomopoulos, Konstantinos
    Nikolopoulou, Vasiliki
    Archimandritis, Athanasios
    Chrysagis, Dimitrios
    Tzourmakliotis, Dimitrios
    Arvanitakis, Constantin
    HEPATOLOGY, 2006, 44 (04) : 339A - 339A
  • [28] An interdisciplinary team approach to hepatitis C evaluation and treatment: assessing the impact of clinical pharmacist involvement on HCV clinical practice and treatment.
    Bagwell, Autumn D.
    Chastain, Cody
    PHARMACOTHERAPY, 2016, 36 (12): : E289 - E289
  • [29] Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication
    Beste, Lauren A.
    Ioannou, George N.
    Larson, Meaghan S.
    Chapko, Michael
    Dominitz, Jason A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (11) : 972 - 978
  • [30] Antipsychotic treatment discontinuation in clinical practice
    Maes, Jan Pieter M. A.
    Nazir, Patricia R. N.
    Delger, Chantal N.
    Breeman, Linda D.
    Van Gool, Arthur R.
    LANCET PSYCHIATRY, 2014, 1 (07): : 500 - 501
12345